Joel A. Tune serves as Executive at UNIGENE LABORATORIES INC, where they oversee executive responsibilities. Since joining the company, Joel A. Tune has executed 9 insider transactions totaling $8.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 1, 2013 involved receiving (via award) 10,000 shares valued at $0.
Joel A. Tune currently holds 263,802 shares of UNIGENE LABORATORIES INC (UGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel A. Tune has been a net buyer of UGNE stock. They have purchased $8.6K and sold $0 worth of shares.
Joel A. Tune's most recent insider trade was on May 1, 2013, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.13 |
| Discretionary |
| Jul 6, 2012 | UGNE | $16.2K | Award | 53,872 | $0.30 | Discretionary |
| May 1, 2012 | UGNE | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 5, 2012 | UGNE | $11.9K | Award | 21,661 | $0.55 | Discretionary |
| Dec 21, 2011 | UGNE | $8.6K | Purchase | 15,000 | $0.57 | Discretionary |
| Jul 6, 2011 | UGNE | $9.0K | Award | 8,654 | $1.04 | Discretionary |
| May 1, 2011 | UGNE | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 5, 2011 | UGNE | $9.0K | Award | 11,538 | $0.78 | Discretionary |